Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/123214
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Coghlan, John Gerry |
dc.contributor.author | Galiè, Nazzareno |
dc.contributor.author | Barberà i Mir, Joan Albert |
dc.contributor.author | Frost, Adaani E. |
dc.contributor.author | Ghofrani, Hossein-Ardeschir |
dc.contributor.author | Hoeper, Marius M |
dc.contributor.author | Kuwana, Masataka |
dc.contributor.author | McLaughlin, Vallerie V. |
dc.contributor.author | Peacock, Andrew J. |
dc.contributor.author | Simonneau, Gérald |
dc.contributor.author | Vachiéry, Jean-Luc |
dc.contributor.author | Blair, Christiana |
dc.contributor.author | Gillies, Hunter |
dc.contributor.author | Miller, Karen L. |
dc.contributor.author | Harris, Julia H. N. |
dc.contributor.author | Langley, Jonathan |
dc.contributor.author | Rubin, Lewis J. |
dc.contributor.author | AMBITION Investigators |
dc.date | 2018-06-25T07:14:45Z |
dc.date | 2018-06-25T07:14:45Z |
dc.date | 2016-12-30 |
dc.date | 2018-06-25T07:14:46Z |
dc.identifier.citation | 0003-4967 |
dc.identifier.citation | 678531 |
dc.identifier.uri | http://hdl.handle.net/2445/123214 |
dc.format | 9 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BMJ Publishing Group |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2016-210236 |
dc.relation | Annals of the Rheumatic Diseases, 2016, vol. 76, num. 7, p. 1219-1227 |
dc.relation | https://doi.org/10.1136/annrheumdis-2016-210236 |
dc.rights | (c) BMJ Publishing Group, 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Hipertensió pulmonar |
dc.subject | Farmacologia |
dc.subject | Lupus |
dc.subject | Malalties autoimmunitàries |
dc.subject | Pulmonary hypertension |
dc.subject | Pharmacology |
dc.subject | Lupus |
dc.subject | Autoimmune diseases |
dc.title | Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |